Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC MRE-269-d7 | 1265295-20-2 | 99.6% | C25H22D7N3O3 | 5 MG
Supplier: Medchemexpress LLC HY79593S25MG
MRE-269-d7 is a deuterium-labeled version of MRE-269, an active metabolite of selexipag that acts as a selective IP receptor agonist. It is intended for research use and can serve as a tracer and an internal standard for quantitative analysis. Deuteration has the potential to affect the pharmacokinetic and metabolic profiles of drugs.
- Deuterium-labeled version of MRE-269
- Active metabolite of selexipag
- Selective IP receptor agonist
- Can be used as a tracer
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Potential to affect pharmacokinetic and metabolic profiles of drugs
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?